Targeting vasopressin signaling in sepsis: Effects of tolvaptan on inflammation and aquaporin dysregulation
- 6 November 2026
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 1040
Abstract
No abstract availableFunding Information
- Atatürk Üniversitesi
This publication has 33 references indexed in Scilit:
- Apremilast ameliorates methotrexate-induced renal injury in rats: role of TLR4/NF-κB/P38 MAPK/caspase-3 and Nrf2/HO-1 signaling pathwaysNaunyn-Schmiedeberg's Archives of Pharmacology, 2025
- Buspirone combats cyclophosphamide-provoked hepatotoxicity in rats via activation of AMPK/Nrf2/HO-1 and suppression of NF-κB p65 /NLRP3 inflammasome pathwaysNaunyn-Schmiedeberg's Archives of Pharmacology, 2025
- Protective effect of tolvaptan against cyclophosphamide‐induced nephrotoxicity in rat modelsPharmacology Research & Perspectives, 2020
- MiR-150 predicts survival in patients with sepsis and inhibits LPS-induced inflammatory factors and apoptosis by targeting NF-κB1 in human umbilical vein endothelial cellsBiochemical and Biophysical Research Communications, 2018
- Ameliorating effects of 1,8-cineole on LPS-induced human umbilical vein endothelial cell injury by suppressing NF-κB signaling in vitroEuropean Journal of Pharmacology, 2016
- AquaporinsCurrent Biology, 2013
- Nonclinical Pharmacokinetics of a New Nonpeptide V2 Receptor Antagonist, TolvaptanCardiovascular Drugs and Therapy, 2011
- Physiology and pathophysiology of the vasopressin-regulated renal water reabsorptionPflügers Archiv - European Journal of Physiology, 2008
- Leucocyte-Endothelial Interactions in Health and Disease2006
- Multisystem organ failure secondary to increased intraabdominal pressureInfection, 1999